Background
Metastatic cancer is usually found in the bone, which is the third most common site of cancer metastasis [1] . Metastatic bone cancer often occurs in the axial skeleton such as pelvis, ribs, skull, and vertebrae [2] . Metastatic cancer of the limbs is frequently found at the proximal end of long bones such as the proximal end of the humerus and femurs [3] . Metastatic cancer of the limbs inevitably causes pain, limb dysfunction and formation of a bump, or even results in pathological fracture. These complications significantly influence the quality of life (QOL) and affect the performance of adjunctive therapies, including chemotherapy and radiotherapy, which may further influence the survival time and the prognosis of these patients [4] [5] [6] .
Non-surgical treatment is a major strategy for the treatment of multiple metastatic bone cancers of limbs, and, in addition to radiation (external beam radiation, radiopharmaceuticals), adjunctive therapies include bisphosphonates and chemotherapeutic agents, ablative techniques (radiofrequency ablation [RFA] and cryoablation), inhibitors of RANK-RANKL interaction (eg, denosumab), hormonal therapies, and interventional techniques (eg, kyphoplasty) [7, 8] . For patients developing pathological fracture at the limbs, palliative surgical treatment is frequently adopted in which the lesions are removed completely, followed by filling of bone cement and fixation with plates and screws or intramedullary nails [9] [10] [11] . These treatments may relieve the pain, but are less beneficial for the recovery of limb function, and weight-bearing walking is usually not possible using a crutch or a walker, so these patients often have poor QOL [12] [13] [14] . For patients with solitary metastatic bone cancer of the limbs, palliative surgical treatment is often clinically preferred [15] . In the present study, solitary metastatic bone cancer of the limbs was treated according to the principles for the treatment of primary bone cancer. En bloc resection was performed, followed by limb-salvage reconstruction of bone defects and limb function. To analyze the effectiveness of this strategy, the pain, QOL, limb function, tumor-free survival and operative complications were evaluated.
Material and Methods

General data
From 2007 to 2010, a total of 27 patients with solitary metastatic bone cancer were treated in our department, including 15 males and 12 females, with a mean age of 58±8.58 years (range: 43-75 years). Follow-up was carried out for 16.15±7.47 months (range: 6-31) (t=1.073, P=0.294). The primary cancers included lung cancer in 7 patients, renal carcinoma in 6, breast cancer in 5, prostate cancer in 2, endometrial carcinoma in 1, thyroid cancer in 1, colon cancer in 1, rectal cancer in 1, liver cancer in 1, glioma in 1, and gastric cancer in 1 patient. Metastatic bone cancer was detected 8~123 months (mean: 42.20±33.61 months) after diagnosis of primary cancers in 20 patients, but metastatic bone cancer as the first sign facilitating the diagnosis of primary cancers was detected in 7 patients. The cancer metastasis sites included the proximal end of the femur in 11 patients, proximal end of the humerus in 6, middle part of the humerus in 3, scapula in 2, middle part of the femur in 2, distal end of the femur in 1, middle part of the ulna in 1, and proximal end of the tibia in 1 patient. The complaints included simple pain in 10 patients, pain and bump in 6, and pathological fracture in 7 patients. Four patients had no complaints and metastatic bone cancer was identified by routine ECT or PET. All data are shown in Table 1 .
Surgical procedures
Limb-salvage surgery was performed in all patients according to the principles for the treatment of primary bone cancer. Artificial prosthetic replacement was performed in 21 patients, simple resection in 2, reconstruction with allogeneic bones in 2, inactivated bone replantation in 1, and removal of hemi-cortex of the bone, filling of bone cerement, and internal fixation in 1 patient. In 7 patients, primary cancer and metastatic bone cancer were identified simultaneously and then a one-stage operation was carried out for resection of primary cancer and metastatic cancer simultaneously. According to the Enneking's Staging System, wide resection was done in 19 patients and marginal resection in 8 patients. In 21 patients, post-operative systemic chemotherapy and/or local radiotherapy were performed, of whom 7 patients receiving marginal resection underwent local radiotherapy post-operatively. Six patients received surgical intervention alone and no adjunctive therapy was carried out.
Post-operative evaluation
QOL and pain were evaluated before and after surgery in 21 patients. Pain was assessed with the 10-point scale before and 1 month after surgery. The QOL was assessed with the SF-36 scale [14] before and 3 months after surgery. Scoring was done by the same physician. Post-operative limb function was evaluated with the American Musculoskeletal Tumor Society (MSTS) system 3 months after surgery.
Statistical analysis
Statistical analysis was performed with SPSS version 14.0. Quantitative data with normal distribution were expressed as mean ± standard deviation to describe the central tendency or discrete tendency. The scores of pain, QOL, and limb function were compared with the t test. Long rank test was employed for survival analysis between groups. Tumorfree survival was defined as the time from the end of surgery to the presence of new lesions. A value of P<0.05 was considered statistically significant.
results
Postoperative complications
All procedures were performed successfully, and no patient died during the follow-up period. Superficial incision infection was found in 2 patients and resolved after debridement. Post-operative prosthesis dislocation occurred in 1 patient and closed reduction was successfully carried out. Deep venous thrombosis was found in 3 patients of whom inferior vena cava filter was placed in 2 and systemic anti-coagulation therapy done in 1 patient. Pulmonary infection was controlled following anti-infection therapy in 1 patient. 
Evaluation of pain, QOL and limb function
As shown in 
Local recurrence
Regarding cancer control, no local recurrence occurred in these 27 patients during the follow-up period. As shown in Figure 1 , log rank testing revealed there was no significant difference in the tumor-free survival between patients receiving wide resection and marginal resection (c Table 2 . Scores of pain and QOL before and after surgery. 
discussion
The bone is the third most common site of cancer metastasis, following lung and liver. In addition to the limbs, the spine is also a common site of cancer metastasis [3, 16] . In the present study, we primarily focus on the surgical treatment of metastatic bone cancer of the limbs. Comprehensive therapy is preferred for the metastatic bone cancer, including surgical intervention, chemotherapy, radiotherapy and other conservative therapies [7, 8, 17] . Metastatic bone cancer is a systemic disease, thus surgical therapy is usually performed on the basis of other adjunctive therapies.
The majority of metastatic bone cancers are predominantly derived from lung cancer and breast cancer, followed by renal carcinoma, thyroid cancer and prostate cancer [18] [19] [20] . Metastatic bone cancer from lung cancer/renal carcinoma is usually characterized by osteolytic lesions [19] , thus patients with this disease are susceptible to pathological fracture, and surgical intervention is required. Metastatic bone cancer from breast cancer/prostate cancer is usually osteogenic, especially in patients with prostate cancer [20] . When compared to patients with osteolytic lesions, those with osteogenic lesions seldom develop pathological fracture; conservative therapy is often performed and surgical intervention less often required [20, 21] . In the present study, 1 patient with prostate cancer developed metastatic bone cancer and subsequent pathological fracture at the proximal end of bilateral femurs. Thus, for metastatic bone cancer patients with osteogenic lesions, the risk for pathological fracture should also be paid attention to, especially in those with intertrochanteric lesions. Mirels score is an important tool for the evaluation of risk for pathological fracture [22] . Patients with a Mirels score of ≥9 are regarded to have high risk for fracture, and active prophylactic surgery is required. For patients developing pathological fracture, determination of surgical intervention is done based on the general conditions: tolerance to surgery, time from identification of primary disease to metastatic bone cancer, disease progression, expected survival time, extent of post-operative QOL improvement, and post-operative limb function [5, 16, 21] . Generally, surgical intervention should be considered for patients with favorable general condition, able to tolerate surgery, having no progression of primary disease, with expected survival time of longer than 6 months, and having poor QOL due to pathological fracture [23, 24] . Once surgical intervention is determined for the treatment of pathological fracture, the requirements are similar to those in the treatment of primary bone cancer. Wide or marginal resection is needed to reconstruct limb function [25] . The reconstruction should be beneficial for the rapid recovery of limb function or partial load-bearing. Usually, artificial prosthetic replacement is performed in patients with lesions near the joint; implantation of allogeneic bone or inactivated cancer-bearing bone, followed by internal fixation with plates, is recommended for patients with lesions at the bone shaft or non-weight-bearing site. In the present study, lesions were mainly found at the site near the joint, and thus artificial prosthetic replacement was the major strategy for the treatment; the post-operative limb function was markedly improved.
For pathological fracture, surgical treatment aims to relieve the pain and improve the QOL and limb function [4, 5, 12] . In the present study, surgical intervention was performed in patients with solitary metastatic bone cancer. Results demonstrate that post-operative pain, QOL, and limb function were dramatically improved. However, for patients with multiple bone metastases, surgical intervention is unable to achieve wide resection or resection of foci, and is usually highly invasive. Under this condition, patients usually have high surgical risk. Moreover, these patients have poor prognosis. Thus, selection of surgical intervention should be cautious [26, 27] .
In the present study, wide resection was performed in the majority of patients and a minority of patients received marginal resection. Post-operative local radiotherapy was also carried out as an adjunctive therapy, achieving favorable control of local tumors. No patients developed local recurrence during the follow-up period. In addition, statistical analysis showed there was no significant difference in the tumor-free survival time between patients receiving wide vs. marginal resection. This demonstrates that only systemic treatment is an effective strategy to improve the survival of cancer patients. Nevertheless, the wide or marginal resection of the cancer plays an important role in the control of local cancer and pain, and improvement of QOL and limb function.
In our study, metastatic bone cancer was the first sign in 7 patients and further examinations identified primary diseases. Of these patients, 6 received 1-stage resection of primary cancer and metastatic bone cancer simultaneously. The remaining patient had prostate cancer and pathological fracture at the proximal end of the bilateral femurs. Bilateral lesions were resectable and treatment was similar to that in patients with solitary metastatic bone cancer. One-stage resection of lesions at bilateral femurs was performed, followed by joint replacement, and endocrine therapy was done as a treatment for primary prostate cancer. For patients with resectable primary and metastatic lesions, post-operative chemotherapy and/or radiotherapy is recommended, which may significantly delay disease progression in the tumor-free survival time, elevate survival rate and improve QOL. This should be done in the presence of completely resectable primary and metastatic lesions. For these patients, resection of a single lesion may pronouncedly affect the effectiveness of adjunctive therapy and survival of cancer-bearing patients.
conclusions
For patients with solitary metastatic bone cancer of the limbs, limb salvage surgery with wide or marginal resection is beneficial for the improvement of post-operative pain, QOL and limb function. In addition, the control of local cancer is also favorable and the local recurrence rate not influenced. For patients with metastatic bone cancer with concomitant primary cancer, 1-stage resection of both lesions is recommended, which may delay disease progression and improve the survival rate. In our study, the time of follow-up was relatively short, and the effect of limb salvage surgery on the overall survival needs to be further investigated in studies with long-term follow-up.
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